Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
Zhen Shen, Tao Cui, Yao Liu, et al.
Phytomedicine (2023) Vol. 121, pp. 155129-155129
Closed Access | Times Cited: 21
Huangqi-Danshen decoction alleviates renal fibrosis through targeting SCD1 to modulate cGAS/STING signaling
Peng Yu, Shanshan Wu, Youcai Xu, et al.
Journal of Ethnopharmacology (2025), pp. 119364-119364
Closed Access
Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
Li Song, Wei Zhang, Shiyun Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116039-116039
Open Access | Times Cited: 14
Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: a real-world longitudinal study
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Dose- and time-dependent renoprotection of Angelica sinensis in patients with chronic kidney disease: A longitudinal cohort study
Hsiao-Tien Chen, Ben‐Hui Yu, Ming-Hsien Yeh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury
Jiahui Liu, Zhongtang Li, Yunlan Lao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Huangqi-Danshen Decoction Against Renal Fibrosis in UUO Mice via TGF-β1 Induced Downstream Signaling Pathway
Xi Huang, Peng Yu, Lingfei Lu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4119-4134
Open Access | Times Cited: 1
Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
Yi‐Chun Chen, Yen‐Chun Chen, Wen‐Yen Chiou, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5612-5612
Open Access | Times Cited: 8
Diterpenoid quinones from the Salvia miltiorrhiza and their lung protective activity
Yingjie Ren, Yan-Gang Cao, Mengnan Zeng, et al.
Fitoterapia (2023) Vol. 167, pp. 105474-105474
Closed Access | Times Cited: 3
Novel therapeutic approaches in the management of chronic kidney disease: a narrative review
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
Postgraduate Medicine (2023) Vol. 135, Iss. 6, pp. 543-550
Closed Access | Times Cited: 2
No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data
Ben‐Hui Yu, Yen‐Chun Chen, Yida Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?
Weili Wang, Rong Dai, Meng Cheng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Utilization of complementary and alternative medicine by patients undergoing maintenance hemodialysis for chronic kidney disease in Taiwan: a descriptive investigation
Ming-Yen Tsai, Chieh-Ying Chin, Wen‐Chin Lee, et al.
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access
Therapeutic effects of Huangqi formula (Eefooton) in chronic kidney disease: clinical research and narrative literature review
Kuo Cheng Lu, Shang-Lun Wu, Tsuo-Cheng Lu, et al.
Aging (2024) Vol. 16, Iss. 22, pp. 13627-13647
Open Access
Dose- and Time-Effects of Renin-Angiotensin Inhibitors on Patients with Advanced Stages 4-5 of Diabetic Kidney Disease
Yi‐Chun Chen, Chien‐Hsueh Tung, Ben‐Hui Yu
Journal of the Endocrine Society (2024) Vol. 8, Iss. 8
Open Access
Alleviating vascular calcification with Bushen Huoxue formula in rats with chronic kidney disease by inhibiting the PTEN/PI3K/AKT signaling pathway through exosomal microRNA-32
Xingyun Guo, Shiwei Liu, Xiaoyi Wu, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access
Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis
Yan Luo, Xuan Chen, Junxiong Cheng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 3
A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease
Yen‐Chun Chen, Yida Li, Ben‐Hui Yu, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Effects of Surgical Treatment for Obstructive Sleep Apnea on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
Juen-Haur Hwang, Ben‐Hui Yu, Yi‐Chun Chen
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4411-4411
Open Access | Times Cited: 1
Bushen Huoxue Formula Alleviates Vascular Calcification in Rats with Chronic Kidney Disease by Inhibiting the Pten/Pi3k/Akt Signaling Pathway Through Exosomal Microrna-32
Xingyun Guo, Shiwei Liu, Xiaoyi Wu, et al.
(2023)
Closed Access
Page 1

Scroll to top